The efficacy of Cognitive Bias Modification as an add-on in smoking cessation: A randomized-controlled double-blind study

Phase 3

• Conditions: F17.2

• Registration Number: DRKS00019221
• Lead Sponsor: udwig-Maximilians-Universität München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 354

Inclusion Criteria

i. Age 18-70 years
ii. CO = 10 ppm
iii. Fagerstrøm Test for Nicotine Dependence = 3
iv. Consumption of at least 10 cigarettes daily within the last 12 months
v. No consumption of nicotine replacement therapy (NRT) and no pharmacological smoking cessation therapry 3 months prior to study participation
vi. Willingness to abstain from NRT, e-cigarettes and any other smoking cessation intervention during study participation
vii. Interest to participate in the smokefree program

Exclusion Criteria

i. Severe psychiatric disorder (e.g., bipolar disorder, psychosis)
ii. Severe neurological disorder (e.g., z.B. Morbus Parkinson, multiple sclerosis)
iii. Acute suicidality
iv. Moderate substance dependence (> criteria fulfilled according to DSM-5; except tobacco)
v. Pregnancy or nursing
vi. Insufficient knowledge of German language

Study & Design

• Study Type: interventional
• Study Design: Not specified